Takeda Pharmaceutical Company Limited ( TAK) - Stock Earnings
TAK Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Oct. 29, 2026, midnight | — / — | — | — / — | — |
TAK Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 673.5 million USD | 7.7 billion USD |
| 2026Q1 | -155.0 million USD | 7.0 billion USD |
| 2026Q2 | 696.0 million USD | 7.5 billion USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
TAK Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 951.5 million USD | 28.2 billion USD |
| 2025 | 722.6 million USD | 30.7 billion USD |
| 2026 | 1.3 billion USD | 29.9 billion USD |
| 2026 Est. | — | — |
TAK
Price: $17.86
Dividend Yield: 3.42%
Forward Dividend Yield: 3.45%
Payout Ratio: 177.09%
Dividend Per Share: 0.62 USD
Earnings Per Share: -0.33 USD
Exchange: NYQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: Japan
Volume: 2.3 million
Market Capitalization: 58.7 billion
Average Dividend Frequency: 2
Years Paying Dividends: 19
DGR3: -2.55%
DGR5: -3.99%
DGR10: -5.34%